NCT06534593

Brief Summary

The current study aims to determine if physical therapy is significantly superior in improving postural stability, pain and function and disc height index in persons with discogenic low back pain, as compared to the standardized medical treatment.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 2, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

August 7, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 7, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 7, 2025

Completed
Last Updated

August 2, 2024

Status Verified

July 1, 2024

Enrollment Period

6 months

First QC Date

July 30, 2024

Last Update Submit

August 1, 2024

Conditions

Outcome Measures

Primary Outcomes (8)

  • Back Pain

    Pain will be measured via Visual Analogue Scale. A higher score signifies poor outcome.

    2 weeks

  • Lumbar Range of Motion

    Lumbar Range of Motion will be measured via inclinometer. A higher score signifies good outcome.

    2 weeks

  • Postural Stability

    Postural Stability will be measured via Biodex Balance System. A higher score signifies poor outcome.

    2 weeks

  • Lumbar Disability

    Lumbar Disability will be measured via Oswestry Disability Index.

    2 weeks

  • Stride length

    Stride length during gait will be analyzed using observational gait analysis. A greater stride length signifies better outcome

    2 weeks

  • Gait Velocity

    Velocity during gait will be analyzed using observational gait analysis. A greater gait velocity signifies better outcome

    2 weeks

  • Cadence

    Cadence during gait will be analyzed using observational gait analysis, which is number of steps per minute.

    2 weeks

  • Disc height index

    Disc height index will be analyzed using Magnetic Resonance Imaging. A greater disc height index signifies better outcome

    2 weeks

Study Arms (2)

Control Group

ACTIVE COMPARATOR

The Control group will receive standard treatment for the management of discogenic low back pain.

Other: Standard medical treatment

Experimental Group

EXPERIMENTAL

The Physical Therapy group will receive Physical Therapy for the management of discogenic low back pain.

Device: Lumbar TractionOther: Mckenzie Extension ProtocolDevice: Interferential TherapyDevice: Heat TherapyOther: Sustained Natural Apophyseal Glides (SNAGs)

Interventions

Standard medical treatment

Control Group

Lumbar traction using traction table

Experimental Group

Mckenzie Extension Exercises

Experimental Group

Interferential Therapy for 20 minutes

Experimental Group

Heat Therapy for 20 minutes

Experimental Group

3-5 reptations of Mulligan's lumbar extension Sustained Natural Apophyseal Glides (SNAGs)

Experimental Group

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Both male and female participants
  • Postero-lateral lumbar disc herniation
  • Aged 18-50 years old
  • Low back pain intensity less than 80/100mm on visual analogue scale or 8/10 on numeric pain rating scale
  • Positive peripheralization and centralization phenomenon

You may not qualify if:

  • Individuals with and any musculoskeletal, metabolic, or neurological disorders that may impair gait, postural stability or sensory integrity will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foundation University Islamabad

Islamabad, Federal, Pakistan

Location

MeSH Terms

Conditions

Intervertebral Disc DisplacementLow Back Pain

Interventions

Electric Stimulation TherapyDiathermy

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsBack PainPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsPhysical Therapy ModalitiesRehabilitationHyperthermia, Induced

Study Officials

  • Muhammad Osama, PhD*

    Foundation University Islamabad

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: the study will consist of 2 arms.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2024

First Posted

August 2, 2024

Study Start

August 7, 2024

Primary Completion

February 7, 2025

Study Completion

February 7, 2025

Last Updated

August 2, 2024

Record last verified: 2024-07

Locations